Compare CCL & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCL | ZTS |
|---|---|---|
| Founded | 1972 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.6B | 31.9B |
| IPO Year | 1994 | 2012 |
| Metric | CCL | ZTS |
|---|---|---|
| Price | $26.49 | $75.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 12 |
| Target Price | $33.99 | ★ $154.18 |
| AVG Volume (30 Days) | ★ 23.1M | 4.9M |
| Earning Date | 03-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.35% | 1.86% |
| EPS Growth | ★ 40.28 | 10.05 |
| EPS | 0.57 | ★ 1.42 |
| Revenue | ★ $18,881,000,000.00 | $9,467,000,000.00 |
| Revenue This Year | $5.69 | $5.63 |
| Revenue Next Year | $3.52 | $4.77 |
| P/E Ratio | ★ $47.06 | $53.17 |
| Revenue Growth | ★ 7.83 | 2.28 |
| 52 Week Low | $23.45 | $71.47 |
| 52 Week High | $34.03 | $160.48 |
| Indicator | CCL | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 41.51 |
| Support Level | $25.61 | $73.39 |
| Resistance Level | $27.78 | $82.66 |
| Average True Range (ATR) | 1.13 | 2.24 |
| MACD | -0.36 | 0.56 |
| Stochastic Oscillator | 25.79 | 45.41 |
Carnival is the largest global cruise company, with nearly 100 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 14 million guests in 2025.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.